Portal de Periódicos da CAPES

Hepatic Progenitors and Strategies for Liver Cell Therapies

2001; Wiley; Volume: 944; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.2001.tb03851.x

1749-6632

Robert Susick, Nicholas Moss, Hiroshi Kubota, Edward L. LeCluyse, Geraldine A. Hamilton, Thomas L. Luntz, John W. Ludlow, Jeffrey H. Fair, David A. Gerber, K. BERGSTRAND, John White, A. Gregory Bruce, O. DRURY, Sanjeev Gupta, Lola M. Reid,

Pluripotent Stem Cells Research

Liver cell therapies, including liver cell transplantation and bioartificial livers, are being developed as alternatives to whole liver transplantation for some patients with severe liver dysfunction. Hepatic progenitors are proposed as ideal cells for use in these liver cell therapies given their ability to expand extensively, differentiate into all mature liver cells, have minimal immunogenicity, be cryopreservable, and reconstitute liver tissue when transplanted. We summarize our ongoing efforts to develop clinical programs of hepatic progenitor cell therapies with a focus on hepatic stem cell biology and strategies that have emerged in analyzing that biology.